A pioneer in the field of in vitro diagnostics, bioMérieux’s innovation strategy is bolstered by significant investments.
bioMérieux devotes considerable resources to its ambitious innovation strategy:
- internal innovation programs capitalizing on more than 55 years of experience and expertise in biology,
- international alliances with academic institutions and private research organizations, the medical community and top life science institutions,
- acquiring new technologies,
- an active international scientific and technology watch and close ties with Institut Mérieux’s research and medical departments,
- substantial financial investment, exceeding the average percentage of sales invested by companies in the diagnostics industry.
|